Case Report: Response to ipilimumab and nivolumab in a patient with adrenocortical carcinoma
ConclusionThis case illustrates the challenge of diagnosing ACC, and that doublet immunotherapy with ipilimumab and nivolumab can have significant clinical efficacy in ACC.
Source: Frontiers in Oncology - Category: Cancer & Oncology Source Type: research
More News: Adrenocortical Carcinoma | Cancer | Cancer & Oncology | Carcinoma | Immunotherapy | Kidney Cancer | Renal Cell Carcinoma | Yervoy